"Our existing healthcare systems are unable to cope with population growth and in particular with the challenges of an aging society. Costs are skyrocketing, with the effect that health may become unaffordable really fast. The key for success is in being able to detect and treat illnesses much, much earlier than we do now. On the one hand, this would improve both the chances for complete recovery and the patients’ quality of life. On the other hand, a big part of the costs incurred for treating developed illnesses could be saved.
In medicine and biology, completely new ideas for innovative solutions are being developed – on a molecular level. Thanks to these innovative technologies, illnesses can be diagnosed at an earlier stage so that many medical interventions and treatments will no longer be necessary. These technologies are the basis for an individual treatment that’s tailored to the needs of each individual patient.“
Products and solutions
The sooner an illness or injury is diagnosed, the better the chances for a complete recovery. A fast, precise, reliable diagnosis is the key to determining the right therapy and avoiding unnecessary medical interventions. Often, it’s imaging techniques that provide doctors with vital diagnostic information.
That’s why Siemens developed the ACUSON P10 a handheld ultrasound system that makes it possible to initiate treatment quickly in emergency situations – minimizing delays when time can be a matter of life and death. Using this mini-ultrasound device, doctors can quickly assess a patient’s condition, anytime and anyplace – whether in the intensive care unit, the outpatient department or a helicopter. Delivering sharp images instantly, the highly versatile ACUSON P10 expedites emergency assessments and initial diagnosis, making it particularly useful for acute care.
This handy little device is a great example of the ways in which Siemens is opening up new horizons in early detection and diagnosis with a broad range of imaging systems.
When it comes to cancer, early detection and treatment is undoubtedly the best medicine. That’s why we’re coordinating our efforts to combat this life-threatening disease, closely linking early diagnostics with focused therapies. Our advanced laboratory tests facilitate the early diagnosis and treatment of prostate carcinomas, for example, while our innovative mammography methods ensure that no time is lost in breast cancer therapy. Our high-resolution, contrast-agent-enhanced imaging methods pinpoint tumors, maximizing diagnostic accuracy and enabling the most appropriate therapy to be determined. What’s more, lab tests and imaging processes based on our technologies can also be used to document the effects of treatment and monitor any recurrence of disease. The seamless integration of new laboratory and imaging technologies, supported by highly efficient information technology, is improving patient outcomes immensely.
In healthcare, vast amounts of administrative and medical data are generated for every patient: medical histories, ECGs, X-ray and other clinical images, lab test results, diagnostic findings and much more. How can doctors be granted fast, secure access to this vital data at any time? With our intelligent healthcare IT solutions and consulting services. We’re improving patient outcomes by providing solutions that optimize workflow across the entire healthcare continuum in hospitals of all sizes. For the numerous hospitals belonging to Rhön-Klinikum AG in Germany, for instance, we cooperated with the clinic-operating company to develop a web-based electronic patient record system. All relevant data for consenting patients is stored in the system, which can be accessed not only by hospital facilities but also by external medical practices. This cutting-edge solution supports decision-making on diagnosis and therapy, saves time and reduces costs – enabling doctors and nursing staff to concentrate more fully on care delivery.
Serious illnesses often go unnoticed until treatment becomes difficult or even impossible. That’s why it’s all the more important to detect disease early ─ so that children grow up healthy and adults stay healthy longer.
We’re the first fully integrated diagnostics company in the world, bringing together in-vitro laboratory diagnostics, in-vivo medical imaging and healthcare information technology solutions.
The key to improving diagnoses and treatment is molecular medicine, which enables processes inside the human body to be understood on the cellular and molecular levels. Illnesses can then be diagnosed earlier and a more personalized treatment provided. We’re cooperating closely with scientists and doctors to push developments in molecular medicine and ensure that patients will increasingly benefit from advanced methods and processes in this promising field.
Biomarkers – such as disease-specific proteins – play an important role in improving early detection. Siemens is currently developing new markers for the early recognition of cancer and Alzheimer‘s disease. Advanced imaging systems – like our PET-CT devices – can localize these markers and trace their activity. To enable doctors to evaluate all available information, we’ve developed GeneSim, an Internet-based knowledge portal. Supplied with patient data, GeneSim searches medical databases around the world to find out which genes and proteins are directly connected with a disease, for example, or which medications may be appropriate. The information extracted by GeneSim is also vital for the development of new tailored medicines. What sounds so futuristic already exists: at the laboratories of Siemens Corporate Technology, this smart Internet platform is already operating successfully.
Thank you for viewing Siemens' Annual Report 2008.
If you require further information, please contact us:
+49 (0)89 636-33032 (Press Office)
+49 (0)89 636-32474 (Investor Relations)
+49 (0)89 636-30085 (Press Office)
+49 (0)89 636-32830 (Investor Relations)
Please send the Annual Report 2008 to the following address: